• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 0500316E
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/13/2022
Event Type  malfunction  
Manufacturer Narrative
Plant investigation: the plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A user facility reported that an internal dialyzer blood leak occurred two minutes after initiation of a patient¿s hemodialysis (hd) treatment.The blood leak alarm occurred when blood hit the venous chamber.No visible blood was noted.The machine, a fresenius 2008t, alarmed appropriately with a blood leak alert.Fresenius bloodlines were being utilized for the treatment.Blood test strips were used and tested positive for the presence of blood.No damage was identified on the dialyzer prior to use.The patient's blood was not returned.Immediately following the event, the patient was re-setup with new supplies on a different machine where they were able to complete treatment.The patient¿s estimated blood loss (ebl) was 200 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was available to be returned for a manufacturer evaluation.
 
Event Description
A user facility reported that an internal dialyzer blood leak occurred two minutes after initiation of a patient¿s hemodialysis (hd) treatment.The blood leak alarm occurred when blood hit the venous chamber.No visible blood was noted.The machine, a fresenius 2008t, alarmed appropriately with a blood leak alert.Fresenius bloodlines were being utilized for the treatment.Blood test strips were used and tested positive for the presence of blood.No damage was identified on the dialyzer prior to use.The patient's blood was not returned.Immediately following the event, the patient was re-setup with new supplies on a different machine where they were able to complete treatment.The patient¿s estimated blood loss (ebl) was 200 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was available to be returned for a manufacturer evaluation.
 
Manufacturer Narrative
Additional information: g2.
 
Event Description
A user facility reported that an internal dialyzer blood leak occurred two minutes after initiation of a patient¿s hemodialysis (hd) treatment.The blood leak alarm occurred when blood hit the venous chamber.No visible blood was noted.The machine, a fresenius 2008t, alarmed appropriately with a blood leak alert.Fresenius bloodlines were being utilized for the treatment.Blood test strips were used and tested positive for the presence of blood.No damage was identified on the dialyzer prior to use.The patient's blood was not returned.Immediately following the event, the patient was re-setup with new supplies on a different machine where they were able to complete treatment.The patient¿s estimated blood loss (ebl) was 200 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was available to be returned for a manufacturer evaluation.
 
Manufacturer Narrative
Correction: h2 in prior submission selected as "additional information" instead of "correction".
 
Event Description
A user facility reported that an internal dialyzer blood leak occurred two minutes after initiation of a patient¿s hemodialysis (hd) treatment.The blood leak alarm occurred when blood hit the venous chamber.No visible blood was noted.The machine, a fresenius 2008t, alarmed appropriately with a blood leak alert.Fresenius bloodlines were being utilized for the treatment.Blood test strips were used and tested positive for the presence of blood.No damage was identified on the dialyzer prior to use.The patient's blood was not returned.Immediately following the event, the patient was re-setup with new supplies on a different machine where they were able to complete treatment.The patient¿s estimated blood loss (ebl) was 200 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was available to be returned for a manufacturer evaluation.
 
Manufacturer Narrative
Plant investigation: the reported complaint was not confirmed as the complaint device was not returned to date for manufacturer evaluation.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was one approved temporary deviation notice (dn) reported on the lot which was unrelated to the complaint event.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.There is no recall associated with this complaint.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas 2018-0171 (vision systems) and 2018-0161 (blood leak reduction) are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 160NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key14436447
MDR Text Key292217810
Report Number0001713747-2022-00164
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100149
UDI-Public00840861100149
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162488
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup,Followup,Followup
Report Date 06/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2023
Device Model Number0500316E
Device Catalogue Number0500316E
Device Lot Number21PU01004
Was Device Available for Evaluation? No
Device AgeMO
Initial Date Manufacturer Received 05/16/2022
Initial Date FDA Received05/19/2022
Supplement Dates Manufacturer Received06/15/2022
06/15/2022
06/16/2022
Supplement Dates FDA Received06/15/2022
06/16/2022
06/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/04/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES
Patient Age68 YR
Patient SexMale
Patient Weight55 KG
-
-